$LIQT

LiqTech (LIQT) Q2 2026 Earnings Call Transcript

LiqTech International (LIQT) reported Q2 FY2026 revenue of $4.4 million, down 12% year over year, citing lower Water for Energy activity and production delays in diesel particulate filters. Gross margin was 8.4% and net loss widened to $3.1 million. Full-year revenue guidance was revised to $20-$23 million. The June offering raised about $18 million net proceeds.

Original reporting
Published Aug 13, 2026, 3:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 3:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
LiqTech (LIQT) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$LIQTBearishMed
01

Why it matters

Management attributes weaker Q2 revenue and margin to lower Water for Energy activity, production delays from raw material constraints, and FX-driven expense increases. It revised full-year revenue guidance downward due to a major Water for Energy project delay, while using June offering proceeds to strengthen liquidity and citing new orders and delivery forecasts.

02

Market read

Traders can reprice LIQT based on the combination of a guidance reset, margin deterioration, and a capital raise that improves near-term balance-sheet resilience, alongside specific new order and delivery timing.

03

What to watch

Gross margin fell to 8.4% and production was constrained by raw material availability; if those constraints ease, the margin and revenue trajectory could improve faster than the guidance implies.

Relevance 9/10Novelty 8/10Timing: pre-market today, Q2 earnings call transcript with guidance cut and capital raise details

Background

LiqTech is a filtration systems company with exposure to water-for-energy, marine emissions treatment (iCER/EGR), and industrial wastewater membranes.

Company-level read

Ticker impact

$LIQTBearishMedium confidence
Context

LiqTech reported Q2 FY2026 revenue of $4.4M, widened net loss to $3.1M, and revised full-year guidance to $20M-$23M after a Water for Energy delay.

Expected impact

Bias to downside or elevated volatility until investors underwrite the delayed Water for Energy project and the execution of industrial wastewater and marine orders.

Evidence & confidence

The article discloses multiple decision-relevant datapoints: revised full-year revenue range, segment drivers of the quarter, cash balance after a capital raise, and a stated delivery timeline for a new order.

Market effects

Highlights demand sensitivity in water-for-energy projects and the importance of industrial wastewater and marine execution for filtration equipment makers.

China marine joint venture progress (factory acceptance test approval) supports regional order visibility, while FX-driven expense pressure is noted.

Shows how project delays and raw-material constraints can quickly reset revenue visibility across multiple end markets.

Counterpoint

The commercial pool segment hit record revenue and the company has a growing order book with defined delivery windows, which could stabilize results even with Water for Energy delays.

Key entities

  • LiqTech International, Inc.

    Reported Q2 FY2026 results, revised full-year revenue guidance, and detailed liquidity actions and new order timing.

  • Fei Chen

    CEO who cited a major customer organizational change delaying a Water for Energy project.

  • David Kowalczyk

    CFO/COO who discussed raw material constraints and FX impacts on expenses.

Related articles

$LIQTMed

LiqTech International, Inc.: LiqTech Secures Follow-On Order from a US-based Steel Manufacturer for Expanded Industrial Wastewater Filtration Capacity

LiqTech International (Nasdaq: LIQT) said it received a follow-on order from a US steel manufacturer for four additional QureFlow filtration systems worth more than $2 million. The expansion follows a 2025 installation and would bring total installed systems to five, with 4,110 membranes and about 1,368 sq m of membrane area.

$LIQTMedAI 9/10

LiqTech International Announces Pricing of $20 Million Underwritten Public Offering of Common Stock

LiqTech International (NASDAQ: LIQT) priced an underwritten public offering of 20,000,000 shares of common stock at $1.00 per share for about $20 million in gross proceeds. The underwriter has a 45-day option for up to 3,000,000 additional shares. Closing is expected June 8, 2026. Net proceeds will repay ~$4.1 million of senior notes and fund growth, working capital, and general corporate uses.

$QTIMedAI 8/10

QT Imaging (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings (QTI) reported Q2 2026 revenue of $7.4 million, up 103% year over year, driven by 15 scanner shipments. First-half revenue was $14 million. Fiscal 2026 guidance calls for about $39 million revenue. Q2 gross margin was 41%; operating loss $1.9 million and net loss $11.1 million. Company extended debt to 2029 and raised $10 million via an offering.

$FENCMed

Adherex Technologies Q2 Earnings Call Highlights

Fennec Pharmaceuticals (NASDAQ:FENC) reported Q2 results on an earnings call. Net product sales were $17.1 million, up 78% year over year. Non-GAAP adjusted EBITDA was $2.8 million versus a $1.2 million loss a year earlier. Cash and cash equivalents were $41.2 million at June 30, 2026. Management cited PEDMARK momentum and no quantitative 2026 revenue outlook.

$MIDDMedAI 8/10

Middleby Q2 Earnings Call Highlights

Middleby (NASDAQ:MIDD) said dealer-channel growth remains positive but should moderate in H2, with Q3 and Q4 growth driven mainly by chain customers. Q2 organic adjusted EBITDA margin was 25.8%, below expectations due to mix, inflation and ice and beverage investments. Q2 adjusted EBITDA was ~$193M and adjusted EPS $2.35. Full-year organic growth outlook raised to 6% to 8%.

$HROWMed

Harrow Q2 Earnings Call Highlights

Harrow (NASDAQ:HROW) reported Q2 revenue of $15.6M for IHEEZO, with demand up to 65,477 units (+44% sequential, +34% YoY) but revenue lagging due to distributor sell-through of prior inventory. Management cited normalized channel inventory, ~25% higher net pricing effective July 1, gross margin 71%, and cash of $83.9M. Harrow also discussed BYOOVIZ launch, VEVYE PBM coverage, and a pending TYRVAYA acquisition.

LiqTech (LIQT) Q2 2026 Earnings Call Transcript — alphai